# CA2+-DEPENDENT PROCESSES INVOLVED IN PHORBOL ESTER TUMOR

> **NIH NIH R01** · UNIVERSITY OF WISCONSIN-MADISON · 1988 · $92,336

## Abstract

The objectives are two-fold:  1) to determine the role of Ca2+-activated,
phospholipid-dependent protein kinase (PKC, a receptor for TPA) in mouse
skin tumor promotion; and 2) to analyze the mechanism by which PKC
activation transduces signal(s) for ornithine decarboxylase (ODS)
induction, a biochemical change associated with skin-tumor promotion by
TPA.  Recently, we found that diacylglycerol (DG), an activator of PKC, and
phospholipase C (which releases DG from membrane phospholipids) induced ODC
activity which correlated with the amount of ODC mRNA in cultured newborn
mouse epidermal cells.  Also, palmitoylcarnitine (PC), an inhibitor of PKC,
inhibited TPA-induced ODC and ODC mRNA and tumor promotion by TPA in intact
mouse skin.  These preliminary results have led us to hypothesize that PKC
activation is an initial event in ODC-gene transcription and skin tumor
promotion by TPA and that TPA-increased ODC mRNA is mediated by
PKC-dependent phosphorylation, directly or indirectly, of nuclear
proteins.  Specifically, we plan to seek answers to the following
questions:  1) Is PKC activation involved in tumor promotion?  In this we
plan to a) determine the tumor promoting activity of agents (e.g.,
diacylglycerols) which activate PKC; b) determine whether the agents which
inhibit PKC (e.g., PC) also proportionally inhibit skin tumor promotion by
TPA; c) determine whether PKC-dependent phosphorylation of endogenous
epidermal proteins correlates to the degree of tumor promotion
susceptibility in B2S, SENCAR, and CD-1 mice.  2) Does PKC affect ODC-gene
transcription in cultured newborn mouse epidermal cells?  3) What are the
physiological protein substrates (targets) for PKC?  4) Does PKC-dependent
phosphorylation of nuclear proteins affect ODC-gene transcription?  Tumor
induction experiments will be performed by the initiation-promotion
protocol.  The rate of ODC-gene transcription will be determined by
measurement of incorporation of (3H)uridine into ODC mRNA by DNA-excess
filter hybridization.  PKC-dependent phosphorylated proteins will be
separated by 2-D gel electrophoresis and then characterized by peptide
mapping and phosphoamino acid analysis.  The role of PKC-mediated
phosphorylated chromosomal proteins in regulating ODC-gene transcription
will be directly examined by determining template activity of reconstituted
chromatin.  This study will permit an evaluation of the role of PKC in ODC
induction and tumor promotion by TPA.

## Key facts

- **NIH application ID:** 3172956
- **Project number:** 5R01CA035368-05
- **Recipient organization:** UNIVERSITY OF WISCONSIN-MADISON
- **SAM.gov UEI:** LCLSJAGTNZQ7
- **Principal Investigator:** AJIT K VERMA
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 1988
- **Award amount:** $92,336
- **Award type:** 5
- **Project period:** 1983-07-01 → 1990-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/3172956

## Citation

> US National Institutes of Health, RePORTER application 3172956, CA2+-DEPENDENT PROCESSES INVOLVED IN PHORBOL ESTER TUMOR (5R01CA035368-05). Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/grant/nih/3172956. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
